Corcept Therapeutics sells Korlym for hypercortisolism and develops other drugs that act on the hormone cortisol. It last closed at $70.07 on Nov 17, up 1.23% on the day. CORT last reported earnings on Tue, Nov 3, 2026. Over the past 90 days StreetAlpha recorded 5 whale options trades in CORT, 20% of them bullish and 80% bearish. In the past 30 days there were 3 dark pool prints totaling $15.7M, the largest $9.1M.
Only 1 firm rated CORT in the past 90 days, not enough for a consensus
Average 12-month target
$173.00
▲ 146.9% upside
Based on 1 analyst who set a price target on CORT in the past 90 days. The average target is $173.00, with a high of $173.00 and a low of $173.00, compared with the last close of $70.07.
Low $173.00Avg $173.00High $173.00
Blue marker: last close $70.07
Highest target$173.00
Average target$173.00
Lowest target$173.00
Latest rating changes
Piper SandlerTarget raised
Nov 4Buy$165 → $173
Piper SandlerReiterated
Jul 30Buy$165
Canaccord GenuityTarget raised
Jul 30Buy$150 → $161
HC Wainwright & Co.Target raised
Jul 30Buy$95 → $165
Canaccord GenuityTarget raised
Jul 29Buy$135 → $150
Date
Firm
Action
Rating
Price target
Nov 4
Piper Sandler
Target raised
Buy
$165 → $173
Jul 30
Piper Sandler
Reiterated
Buy
$165
Jul 30
Canaccord Genuity
Target raised
Buy
$150 → $161
Jul 30
HC Wainwright & Co.
Target raised
Buy
$95 → $165
Jul 29
Canaccord Genuity
Target raised
Buy
$135 → $150
Loading…
Technical Analysis
CORT · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, oversold
The stock is 16% below its 20 day and 46% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot at $69.82, and the nearest resistance the Pivot R1 at $71.96.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.3%/day
Key levels
$126.3852 week high+80.4%
$103.29100 day average+47.4%
$101.9750 day average+45.5%
$85.40Swing high (Jun 17)+21.9%
$81.6320 day average+16.5%
$76.79200 day average+9.6%
$71.96Pivot R1+2.7%
$70.07Last close
$69.82Pivot−0.4%
$67.94Pivot S1−3.0%
$28.6652 week low−59.1%
Indicators
RSI (14)
25.30
Oversold below 30
Oversold
MACD
-9.76
Below its signal line
Bearish
Stochastic
9.3
Near the bottom of its range
Oversold
ADX (14)
48.5
Strong downtrend
Williams %R
-88.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-92.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.5%
Change over 10 sessions
Bearish
ATR (14)
$5.12
Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 15.2%/day
Key levels
$126.3852 week high+80.4%
$103.29100 day average+47.4%
$101.9750 day average+45.5%
$85.40Swing high (Jun 17)+21.9%
$81.6320 day average+16.5%
$76.79200 day average+9.6%
$71.96Pivot R1+2.7%
$70.07Last close
$69.82Pivot−0.4%
$67.94Pivot S1−3.0%
$28.6652 week low−59.1%
Indicators
RSI (14)
36.96
Weak, oversold below 30
Neutral
MACD
0.47
Below its signal line
Bearish
Stochastic
3.7
Near the bottom of its range
Oversold
ADX (14)
39.5
Trending down
Williams %R
-96.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-150.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−37.9%
Change over 10 sessions
Bearish
ATR (14)
$10.65
Typical daily range, 15.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for CORT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bearish1 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow CORT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CORT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CORT is in one of them and how their past CORT trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company based in Redwood City, California, that develops medicines acting on the hormone cortisol. Its main product is Korlym, along with a generic version of it, used to treat hypercortisolism, also called Cushing's syndrome. The company sells these products in the United States through sales representatives who call on physicians treating patients with the condition. It is also testing cortisol-related drug candidates for other conditions, including some cancers, ALS and a liver disease.